Bluelinea Société Anonyme (EPA:ALBLU)
0.4100
-0.0020 (-0.49%)
May 29, 2026, 4:27 PM CET
Bluelinea Société Anonyme Revenue
In the year 2025, Bluelinea Société Anonyme had annual revenue of 11.12M EUR with 2.36% growth. Bluelinea Société Anonyme had revenue of 5.75M in the half year ending December 31, 2025, with 4.55% growth.
Revenue
11.12M
Revenue Growth
+2.36%
P/S Ratio
0.68
Revenue / Employee
124.96K
Employees
89
Market Cap
7.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.12M | 256.44K | 2.36% |
| Dec 31, 2024 | 10.86M | -92.82K | -0.85% |
| Dec 31, 2023 | 10.96M | -485.42K | -4.24% |
| Dec 31, 2022 | 11.44M | 3.35M | 41.33% |
| Dec 31, 2021 | 8.10M | 848.69K | 11.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Biosynex | 115.13M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.47M |
| Novacyt | 22.96M |
| Implanet | 12.47M |
| Mauna Kea Technologies | 8.91M |
| SpineGuard | 3.76M |